25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Australian Clinical Labs Ltd
Buy, Hold or Sell?

Let's analyze Australian Clinical Labs Ltd together

I guess you are interested in Australian Clinical Labs Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Australian Clinical Labs Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Australian Clinical Labs Ltd

I send you an email if I find something interesting about Australian Clinical Labs Ltd.

1. Quick Overview

1.1. Quick analysis of Australian Clinical Labs Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Australian Clinical Labs Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.25
When do you have the money?
1 year
How often do you get paid?
87.5%

What is your share worth?

Current worth
A$0.89
Expected worth in 1 year
A$1.00
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
A$0.51
Return On Investment
13.6%

For what price can you sell your share?

Current Price per Share
A$3.75
Expected price per share
A$3.58 - A$3.84
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Australian Clinical Labs Ltd (5 min.)




Live pricePrice per Share (EOD)
A$3.75
Intrinsic Value Per Share
A$6.31 - A$15.24
Total Value Per Share
A$7.20 - A$16.13

2.2. Growth of Australian Clinical Labs Ltd (5 min.)




Is Australian Clinical Labs Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$112.9m$109.7m$3.2m2.9%

How much money is Australian Clinical Labs Ltd making?

Current yearPrevious yearGrowGrow %
Making money$15.2m$22.8m-$7.6m-50.0%
Net Profit Margin3.5%5.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Australian Clinical Labs Ltd (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#62 / 134

Most Revenue
#26 / 134

Most Profit
#27 / 134
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Australian Clinical Labs Ltd?

Welcome investor! Australian Clinical Labs Ltd's management wants to use your money to grow the business. In return you get a share of Australian Clinical Labs Ltd.

First you should know what it really means to hold a share of Australian Clinical Labs Ltd. And how you can make/lose money.

Speculation

The Price per Share of Australian Clinical Labs Ltd is A$3.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Australian Clinical Labs Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Australian Clinical Labs Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.89. Based on the TTM, the Book Value Change Per Share is A$0.03 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Australian Clinical Labs Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.082.0%0.082.0%0.113.0%0.215.7%0.123.1%
Usd Book Value Change Per Share0.020.5%0.020.5%-0.19-5.0%0.102.5%0.071.9%
Usd Dividend Per Share0.061.7%0.061.7%0.318.2%0.143.8%0.123.2%
Usd Total Gains Per Share0.082.2%0.082.2%0.123.2%0.246.3%0.195.1%
Usd Price Per Share1.84-1.84-1.89-1.53-0.96-
Price to Earnings Ratio24.22-24.22-16.69-9.58-5.99-
Price-to-Total Gains Ratio22.73-22.73-16.02-15.30-15.30-
Price to Book Ratio3.26-3.26-3.47-2.42-1.51-
Price-to-Total Gains Ratio22.73-22.73-16.02-15.30-15.30-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.38275
Number of shares419
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.060.14
Usd Book Value Change Per Share0.020.10
Usd Total Gains Per Share0.080.24
Gains per Quarter (419 shares)33.8699.52
Gains per Year (419 shares)135.42398.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
110630125238160388
221259260476320786
3318893957154801184
44241185309536401582
553014866511917991980
663517780014299592378
7741207935166711192776
88472361070190612793174
99532661205214414393572
1010592951340238215993970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.03.00.062.5%5.03.00.062.5%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%6.02.00.075.0%6.02.00.075.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.01.087.5%7.00.01.087.5%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Australian Clinical Labs Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0280.0280%-0.296+1167%0.150-82%0.111-75%
Book Value Per Share--0.8860.8860%0.859+3%0.730+21%0.485+83%
Current Ratio--0.6430.6430%0.617+4%0.686-6%0.819-21%
Debt To Asset Ratio--0.7000.7000%0.7020%0.734-5%0.791-11%
Debt To Equity Ratio--2.3392.3390%2.356-1%3.100-25%6.059-61%
Dividend Per Share--0.0990.0990%0.482-79%0.224-56%0.192-48%
Enterprise Value--191214640.000191214640.0000%213037666.800-10%428118729.867-55%428118729.867-55%
Eps--0.1190.1190%0.179-33%0.337-65%0.184-35%
Ev To Ebitda Ratio--1.1271.1270%1.152-2%1.547-27%1.547-27%
Ev To Sales Ratio--0.2770.2770%0.308-10%0.492-44%0.492-44%
Free Cash Flow Per Share--0.7630.7630%0.680+12%0.785-3%0.478+60%
Free Cash Flow To Equity Per Share--0.0350.0350%-0.006+116%0.075-54%0.051-33%
Gross Profit Margin---8.421-8.4210%1.000-942%-0.884-90%-0.178-98%
Intrinsic Value_10Y_max--15.245--------
Intrinsic Value_10Y_min--6.312--------
Intrinsic Value_1Y_max--1.050--------
Intrinsic Value_1Y_min--0.754--------
Intrinsic Value_3Y_max--3.519--------
Intrinsic Value_3Y_min--2.174--------
Intrinsic Value_5Y_max--6.427--------
Intrinsic Value_5Y_min--3.482--------
Market Cap752160000.000+23%579664640.000579664640.0000%599324666.800-3%485641237.920+19%303525773.700+91%
Net Profit Margin--0.0350.0350%0.052-33%0.089-61%0.041-15%
Operating Margin--0.0600.0600%0.090-33%0.133-55%0.072-17%
Operating Ratio--0.7600.7600%0.925-18%0.844-10%0.915-17%
Pb Ratio4.231+23%3.2613.2610%3.471-6%2.421+35%1.513+116%
Pe Ratio31.426+23%24.21924.2190%16.694+45%9.584+153%5.990+304%
Price Per Share3.750+23%2.8902.8900%2.980-3%2.414+20%1.509+92%
Price To Free Cash Flow Ratio4.913+23%3.7873.7870%4.383-14%2.584+47%1.615+134%
Price To Total Gains Ratio29.489+23%22.72622.7260%16.015+42%15.300+49%15.300+49%
Quick Ratio--0.5250.5250%0.483+9%0.567-7%0.652-20%
Return On Assets--0.0400.0400%0.062-35%0.125-68%0.035+14%
Return On Equity--0.1350.1350%0.208-35%0.489-72%-0.161+220%
Total Gains Per Share--0.1270.1270%0.186-32%0.374-66%0.302-58%
Usd Book Value--112951881.000112951881.0000%109715153.400+3%93263376.600+21%62022585.375+82%
Usd Book Value Change Per Share--0.0180.0180%-0.188+1167%0.095-82%0.070-75%
Usd Book Value Per Share--0.5630.5630%0.546+3%0.464+21%0.308+83%
Usd Dividend Per Share--0.0630.0630%0.306-79%0.142-56%0.122-48%
Usd Enterprise Value--121497782.256121497782.2560%135364133.485-10%272026640.957-55%272026640.957-55%
Usd Eps--0.0760.0760%0.113-33%0.214-65%0.117-35%
Usd Free Cash Flow--97271479.80097271479.8000%86889043.800+12%100314664.560-3%61104432.375+59%
Usd Free Cash Flow Per Share--0.4850.4850%0.432+12%0.499-3%0.304+60%
Usd Free Cash Flow To Equity Per Share--0.0220.0220%-0.004+116%0.048-54%0.033-33%
Usd Market Cap477922464.000+23%368318912.256368318912.2560%380810893.285-3%308576442.574+19%192860276.609+91%
Usd Price Per Share2.383+23%1.8361.8360%1.893-3%1.534+20%0.959+92%
Usd Profit--15207663.60015207663.6000%22811495.400-33%43169965.560-65%23520919.500-35%
Usd Revenue--438253171.200438253171.2000%439762246.2000%444776187.600-1%370256793.300+18%
Usd Total Gains Per Share--0.0810.0810%0.118-32%0.238-66%0.192-58%
 EOD+4 -4MRQTTM+0 -0YOY+19 -215Y+10 -3010Y+16 -24

3.3 Fundamental Score

Let's check the fundamental score of Australian Clinical Labs Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1531.426
Price to Book Ratio (EOD)Between0-14.231
Net Profit Margin (MRQ)Greater than00.035
Operating Margin (MRQ)Greater than00.060
Quick Ratio (MRQ)Greater than10.525
Current Ratio (MRQ)Greater than10.643
Debt to Asset Ratio (MRQ)Less than10.700
Debt to Equity Ratio (MRQ)Less than12.339
Return on Equity (MRQ)Greater than0.150.135
Return on Assets (MRQ)Greater than0.050.040
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Australian Clinical Labs Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.750
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Australian Clinical Labs Ltd

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Fundamental data was last updated by Penke on 2025-02-15 23:57:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Australian Clinical Labs Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 3.5% means that $0.03 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Australian Clinical Labs Ltd:

  • The MRQ is 3.5%. The company is making a profit. +1
  • The TTM is 3.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.5%TTM3.5%0.0%
TTM3.5%YOY5.2%-1.7%
TTM3.5%5Y8.9%-5.4%
5Y8.9%10Y4.1%+4.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5%-5.4%+8.9%
TTM3.5%-10.3%+13.8%
YOY5.2%1.2%+4.0%
5Y8.9%-3.0%+11.9%
10Y4.1%1.0%+3.1%
4.3.1.2. Return on Assets

Shows how efficient Australian Clinical Labs Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • 4.0% Return on Assets means that Australian Clinical Labs Ltd generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Australian Clinical Labs Ltd:

  • The MRQ is 4.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.0%TTM4.0%0.0%
TTM4.0%YOY6.2%-2.2%
TTM4.0%5Y12.5%-8.5%
5Y12.5%10Y3.5%+9.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0%-1.3%+5.3%
TTM4.0%-1.7%+5.7%
YOY6.2%-0.5%+6.7%
5Y12.5%-+12.5%
10Y3.5%-0.2%+3.7%
4.3.1.3. Return on Equity

Shows how efficient Australian Clinical Labs Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • 13.5% Return on Equity means Australian Clinical Labs Ltd generated $0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Australian Clinical Labs Ltd:

  • The MRQ is 13.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.5%TTM13.5%0.0%
TTM13.5%YOY20.8%-7.3%
TTM13.5%5Y48.9%-35.4%
5Y48.9%10Y-16.1%+65.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ13.5%-0.8%+14.3%
TTM13.5%-2.4%+15.9%
YOY20.8%0.3%+20.5%
5Y48.9%-0.2%+49.1%
10Y-16.1%-0.8%-15.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Australian Clinical Labs Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Australian Clinical Labs Ltd is operating .

  • Measures how much profit Australian Clinical Labs Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • An Operating Margin of 6.0% means the company generated $0.06  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Australian Clinical Labs Ltd:

  • The MRQ is 6.0%. The company is operating less efficient.
  • The TTM is 6.0%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.0%TTM6.0%0.0%
TTM6.0%YOY9.0%-3.0%
TTM6.0%5Y13.3%-7.4%
5Y13.3%10Y7.2%+6.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0%-12.7%+18.7%
TTM6.0%-20.2%+26.2%
YOY9.0%2.6%+6.4%
5Y13.3%-0.3%+13.6%
10Y7.2%2.9%+4.3%
4.3.2.2. Operating Ratio

Measures how efficient Australian Clinical Labs Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.76 means that the operating costs are $0.76 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Australian Clinical Labs Ltd:

  • The MRQ is 0.760. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.760. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.760TTM0.7600.000
TTM0.760YOY0.925-0.165
TTM0.7605Y0.844-0.084
5Y0.84410Y0.915-0.072
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7601.243-0.483
TTM0.7601.254-0.494
YOY0.9251.252-0.327
5Y0.8441.230-0.386
10Y0.9151.201-0.286
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Australian Clinical Labs Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Australian Clinical Labs Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 0.64 means the company has $0.64 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Australian Clinical Labs Ltd:

  • The MRQ is 0.643. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.643. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.643TTM0.6430.000
TTM0.643YOY0.617+0.026
TTM0.6435Y0.686-0.042
5Y0.68610Y0.819-0.133
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6432.116-1.473
TTM0.6432.076-1.433
YOY0.6172.585-1.968
5Y0.6862.657-1.971
10Y0.8193.241-2.422
4.4.3.2. Quick Ratio

Measures if Australian Clinical Labs Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.52 means the company can pay off $0.52 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Australian Clinical Labs Ltd:

  • The MRQ is 0.525. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.525. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.525TTM0.5250.000
TTM0.525YOY0.483+0.041
TTM0.5255Y0.567-0.042
5Y0.56710Y0.652-0.085
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5251.266-0.741
TTM0.5251.317-0.792
YOY0.4831.701-1.218
5Y0.5671.983-1.416
10Y0.6522.404-1.752
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Australian Clinical Labs Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Australian Clinical Labs Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Australian Clinical Labs Ltd to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.70 means that Australian Clinical Labs Ltd assets are financed with 70.0% credit (debt) and the remaining percentage (100% - 70.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Australian Clinical Labs Ltd:

  • The MRQ is 0.700. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.700. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.700TTM0.7000.000
TTM0.700YOY0.702-0.001
TTM0.7005Y0.734-0.034
5Y0.73410Y0.791-0.057
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7000.437+0.263
TTM0.7000.439+0.261
YOY0.7020.368+0.334
5Y0.7340.416+0.318
10Y0.7910.448+0.343
4.5.4.2. Debt to Equity Ratio

Measures if Australian Clinical Labs Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 233.9% means that company has $2.34 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Australian Clinical Labs Ltd:

  • The MRQ is 2.339. The company is just not able to pay all its debts with equity.
  • The TTM is 2.339. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.339TTM2.3390.000
TTM2.339YOY2.356-0.017
TTM2.3395Y3.100-0.760
5Y3.10010Y6.059-2.960
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3390.661+1.678
TTM2.3390.686+1.653
YOY2.3560.512+1.844
5Y3.1000.687+2.413
10Y6.0590.717+5.342
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Australian Clinical Labs Ltd generates.

  • Above 15 is considered overpriced but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • A PE ratio of 24.22 means the investor is paying $24.22 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Australian Clinical Labs Ltd:

  • The EOD is 31.426. Based on the earnings, the company is overpriced. -1
  • The MRQ is 24.219. Based on the earnings, the company is fair priced.
  • The TTM is 24.219. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD31.426MRQ24.219+7.207
MRQ24.219TTM24.2190.000
TTM24.219YOY16.694+7.525
TTM24.2195Y9.584+14.635
5Y9.58410Y5.990+3.594
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD31.426-0.301+31.727
MRQ24.219-0.693+24.912
TTM24.219-0.908+25.127
YOY16.6940.035+16.659
5Y9.5841.970+7.614
10Y5.9907.009-1.019
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Australian Clinical Labs Ltd:

  • The EOD is 4.913. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.787. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 3.787. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.913MRQ3.787+1.127
MRQ3.787TTM3.7870.000
TTM3.787YOY4.383-0.596
TTM3.7875Y2.584+1.202
5Y2.58410Y1.615+0.969
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD4.913-0.079+4.992
MRQ3.787-0.016+3.803
TTM3.787-0.510+4.297
YOY4.383-2.094+6.477
5Y2.584-1.205+3.789
10Y1.615-1.738+3.353
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Australian Clinical Labs Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 3.26 means the investor is paying $3.26 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Australian Clinical Labs Ltd:

  • The EOD is 4.231. Based on the equity, the company is fair priced.
  • The MRQ is 3.261. Based on the equity, the company is fair priced.
  • The TTM is 3.261. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.231MRQ3.261+0.970
MRQ3.261TTM3.2610.000
TTM3.261YOY3.471-0.210
TTM3.2615Y2.421+0.840
5Y2.42110Y1.513+0.908
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD4.2312.053+2.178
MRQ3.2612.304+0.957
TTM3.2612.272+0.989
YOY3.4712.368+1.103
5Y2.4213.713-1.292
10Y1.5134.140-2.627
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets593,060
Total Liabilities415,295
Total Stockholder Equity177,528
 As reported
Total Liabilities 415,295
Total Stockholder Equity+ 177,528
Total Assets = 593,060

Assets

Total Assets593,060
Total Current Assets133,601
Long-term Assets459,459
Total Current Assets
Cash And Cash Equivalents 26,136
Short-term Investments 709
Net Receivables 81,434
Inventory 16,826
Other Current Assets 8,496
Total Current Assets  (as reported)133,601
Total Current Assets  (calculated)133,601
+/-0
Long-term Assets
Property Plant Equipment 281,704
Goodwill 158,684
Intangible Assets 6,260
Long-term Assets Other 2,068
Long-term Assets  (as reported)459,459
Long-term Assets  (calculated)448,716
+/- 10,743

Liabilities & Shareholders' Equity

Total Current Liabilities207,703
Long-term Liabilities207,592
Total Stockholder Equity177,528
Total Current Liabilities
Short-term Debt 104,709
Accounts payable 26,187
Other Current Liabilities 73,571
Total Current Liabilities  (as reported)207,703
Total Current Liabilities  (calculated)204,467
+/- 3,236
Long-term Liabilities
Long term Debt 55,064
Capital Lease Obligations Min Short Term Debt149,126
Long-term Liabilities  (as reported)207,592
Long-term Liabilities  (calculated)204,190
+/- 3,402
Total Stockholder Equity
Common Stock791,762
Retained Earnings 159,054
Accumulated Other Comprehensive Income -773,288
Total Stockholder Equity (as reported)177,528
Total Stockholder Equity (calculated)177,528
+/-0
Other
Capital Stock791,762
Cash and Short Term Investments 26,845
Common Stock Shares Outstanding 199,472
Current Deferred Revenue3,236
Liabilities and Stockholders Equity 593,060
Net Debt 282,763
Net Invested Capital 232,592
Net Working Capital -74,102
Property Plant and Equipment Gross 411,494
Short Long Term Debt Total 308,899



6.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
120,893
119,058
153,610
366,053
474,701
628,042
578,913
593,060
593,060578,913628,042474,701366,053153,610119,058120,893
   > Total Current Assets 
58,347
61,462
64,805
112,100
117,226
142,871
115,959
133,601
133,601115,959142,871117,226112,10064,80561,46258,347
       Cash And Cash Equivalents 
7,036
6,867
4,131
34,849
35,233
26,372
19,955
26,136
26,13619,95526,37235,23334,8494,1316,8677,036
       Short-term Investments 
301
2,914
1,001
435
1,049
1,134
632
709
7096321,1341,0494351,0012,914301
       Net Receivables 
29,278
41,162
44,617
61,805
62,976
87,471
70,263
81,434
81,43470,26387,47162,97661,80544,61741,16229,278
       Inventory 
7,695
7,122
9,670
10,498
13,356
20,088
15,092
16,826
16,82615,09220,08813,35610,4989,6707,1227,695
       Other Current Assets 
14,037
12,000
5,386
4,513
1,049
7,806
10,017
8,496
8,49610,0177,8061,0494,5135,38612,00014,037
   > Long-term Assets 
62,546
57,596
88,805
253,953
357,475
485,171
462,954
459,459
459,459462,954485,171357,475253,95388,80557,59662,546
       Property Plant Equipment 
37,879
33,666
41,801
194,053
228,944
310,200
288,438
281,704
281,704288,438310,200228,944194,05341,80133,66637,879
       Goodwill 
13,002
13,002
35,748
35,748
105,983
158,684
158,684
158,684
158,684158,684158,684105,98335,74835,74813,00213,002
       Long Term Investments 
0
0
0
0
1,000
0
0
0
0001,0000000
       Intangible Assets 
0
35,748
35,748
112,906
6,923
6,716
6,488
6,260
6,2606,4886,7166,923112,90635,74835,7480
       Other Assets 
11,665
10,418
10,894
23,164
15,625
9,571
0
0
009,57115,62523,16410,89410,41811,665
> Total Liabilities 
106,771
113,600
126,190
297,065
392,787
395,485
406,242
415,295
415,295406,242395,485392,787297,065126,190113,600106,771
   > Total Current Liabilities 
54,241
57,443
66,395
135,466
166,176
225,163
187,925
207,703
207,703187,925225,163166,176135,46666,39557,44354,241
       Short-term Debt 
203
1,307
0
61,641
70,206
-2,954
32,348
104,709
104,70932,348-2,95470,20661,64101,307203
       Short Long Term Debt 
0
0
0
0
300
0
0
0
0003000000
       Accounts payable 
7,466
9,121
11,975
12,890
17,025
26,468
17,966
26,187
26,18717,96626,46817,02512,89011,9759,1217,466
       Other Current Liabilities 
46,572
46,994
54,420
55,538
675
6,207
137
73,571
73,5711376,20767555,53854,42046,99446,572
   > Long-term Liabilities 
52,530
56,157
59,795
161,599
226,611
170,322
218,317
207,592
207,592218,317170,322226,611161,59959,79556,15752,530
       Long term Debt Total 
48,264
52,213
55,999
157,765
224,055
167,610
0
0
00167,610224,055157,76555,99952,21348,264
       Other Liabilities 
4,266
3,944
3,796
3,834
2,556
2,712
0
0
002,7122,5563,8343,7963,9444,266
> Total Stockholder Equity
14,122
5,458
27,420
68,988
81,898
232,444
172,417
177,528
177,528172,417232,44481,89868,98827,4205,45814,122
   Common Stock
109,515
109,515
146,505
146,505
797,975
793,031
792,140
791,762
791,762792,140793,031797,975146,505146,505109,515109,515
   Retained Earnings 
-224,824
-233,836
-120,288
-120,288
62,194
216,220
155,241
159,054
159,054155,241216,22062,194-120,288-120,288-233,836-224,824
   Accumulated Other Comprehensive Income 
442
129,779
1,203
42,771
-778,271
-776,807
-774,964
-773,288
-773,288-774,964-776,807-778,27142,7711,203129,779442
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
128,989
128,989
0
1,516
-645,483
-644,019
-642,176
0
0-642,176-644,019-645,4831,5160128,989128,989



6.3. Balance Sheets

Currency in AUD. All numbers in thousands.




6.4. Cash Flows

Currency in AUD. All numbers in thousands.




6.5. Income Statements

Currency in AUD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue689,728
Cost of Revenue-442,368
Gross Profit247,360247,360
 
Operating Income (+$)
Gross Profit247,360
Operating Expense-81,547
Operating Income56,905165,813
 
Operating Expense (+$)
Research Development0
Selling General Administrative312,668
Selling And Marketing Expenses225,475
Operating Expense81,547538,143
 
Net Interest Income (+$)
Interest Income501
Interest Expense-17,040
Other Finance Cost-0
Net Interest Income-16,539
 
Pretax Income (+$)
Operating Income56,905
Net Interest Income-16,539
Other Non-Operating Income Expenses0
Income Before Tax (EBT)36,36677,444
EBIT - interestExpense = 24,183
36,056
40,974
Interest Expense17,040
Earnings Before Interest and Taxes (EBIT)41,22353,406
Earnings Before Interest and Taxes (EBITDA)169,650
 
After tax Income (+$)
Income Before Tax36,366
Tax Provision-12,122
Net Income From Continuing Ops24,24424,244
Net Income23,934
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses632,823
Total Other Income/Expenses Net-20,53916,539
 

Technical Analysis of Australian Clinical Labs Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Australian Clinical Labs Ltd. The general trend of Australian Clinical Labs Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Australian Clinical Labs Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Australian Clinical Labs Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 3.8 < 3.83 < 3.84.

The bearish price targets are: 3.63 > 3.58 > 3.58.

Tweet this
Australian Clinical Labs Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Australian Clinical Labs Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Australian Clinical Labs Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAustralian Clinical Labs Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Australian Clinical Labs Ltd. The current adx is .

Australian Clinical Labs Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily Relative Strength Index (RSI) ChartAustralian Clinical Labs Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily Stochastic Oscillator ChartAustralian Clinical Labs Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily Commodity Channel Index (CCI) ChartAustralian Clinical Labs Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily Chande Momentum Oscillator (CMO) ChartAustralian Clinical Labs Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily Williams %R ChartAustralian Clinical Labs Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily Average True Range (ATR) ChartAustralian Clinical Labs Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily On-Balance Volume (OBV) ChartAustralian Clinical Labs Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily Money Flow Index (MFI) ChartAustralian Clinical Labs Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Australian Clinical Labs Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-12-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Australian Clinical Labs Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Australian Clinical Labs Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.750
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Australian Clinical Labs Ltd with someone you think should read this too:
  • Are you bullish or bearish on Australian Clinical Labs Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Australian Clinical Labs Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Australian Clinical Labs Ltd

I send you an email if I find something interesting about Australian Clinical Labs Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Australian Clinical Labs Ltd.

Receive notifications about Australian Clinical Labs Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.